MedWatch

Industry veteran assumes chief commercial officer role at Novo Nordisk Pharmatech

On October 1, the pharmaceutical firm welcomed a veteran with more than 20 years of experience from the industry on board.

Samia Kappe is Novo Nordisk Pharmatech's new chief commercial officer | Photo: Viminco / PR

Pharmaceutical firm Novo Nordisk Pharmatech has been on the lookout for a new chief commercial officer for some time, but the hunt has now come to an end.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs